urocanic acid has been researched along with Dermatitis, Atopic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, R; Dev, K; Dinish, US; Ho, CJH; Kuan, AHY; Li, X; Moothanchery, M; Olivo, M; Perumal, J; Singh, G; Thng, STG; Wong, MKW; Yew, YW | 1 |
| Hart, PH; Norval, M | 1 |
| Fluhr, JW; Friess, W; Henkes, D; Küchler, S; Meier, RJ; Schäfer-Korting, M; Schreml, S; Školová, B; Sochorová, M; Strüver, K; Vávrová, K; Witting, MY | 1 |
| Jansén, CT; Laihia, JK; Lehtinen, T; Leino, L; Peltonen, JM; Pylkkänen, L; Volanen, I | 1 |
| Brown, SJ; Campbell, LE; Irvine, AD; Jakasa, I; Kezic, S; Kroboth, K; McLean, WH; O'Regan, GM; Sandilands, A; Thawer-Esmail, F; Todd, G; Wen, Y | 1 |
| Aslam, I; Feldman, SR; Sandoval, LF | 1 |
| Bruhs, A; Eckhart, L; Schwarz, A; Schwarz, T; Tschachler, E | 1 |
| Fallon, PG; Foster, TJ; Irvine, AD; Miajlovic, H | 1 |
| Campbell, LE; Chen, H; Irvine, AD; Kezic, S; Kroboth, K; McLean, WH; O'Regan, GM; Rowland, M; Sandilands, A; Watson, R; Yau, N | 1 |
| Brown, SJ; Campbell, LE; Cordell, HJ; Irvine, AD; Kezic, S; Kroboth, K; McLean, WH; Pohler, E; Sandilands, A | 1 |
| Berg, ND; Bisgaard, H; Bønnelykke, K; Carlsen, BC; Carson, CG; Heickendorff, L; Heinrich, J; Huth, C; Johansen, JD; Krämer, U; Kratzsch, J; Linneberg, A; Meldgaard, M; Menné, T; Munk, M; Schwab, S; Standl, M; Stender, S; Szecsi, PB; Thorand, B; Thuesen, B; Thyssen, JP; Wallaschofski, H; Weidinger, S | 1 |
| Ayräs, P; Jansén, CT; Kalimo, K; Lammintausta, K; Neuvonen, K; Pasanen, P; Varjonen, E | 1 |
2 review(s) available for urocanic acid and Dermatitis, Atopic
| Article | Year |
|---|---|
The Multiple Roles of Urocanic Acid in Health and Disease.
Topics: Brain; Carcinogenesis; Dermatitis, Atopic; Humans; Hydrogen-Ion Concentration; Liver; Multiple Sclerosis; Signal Transduction; Skin; Skin Neoplasms; Stereoisomerism; Ultraviolet Rays; Urocanic Acid; Urticaria | 2021 |
What's new in the topical treatment of allergic skin diseases.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Calcineurin Inhibitors; Dermatitis, Allergic Contact; Dermatitis, Atopic; Evidence-Based Medicine; Humans; Lipoxins; Randomized Controlled Trials as Topic; Skin; Urocanic Acid | 2014 |
1 trial(s) available for urocanic acid and Dermatitis, Atopic
| Article | Year |
|---|---|
Three randomised phase I/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis.
Topics: Administration, Cutaneous; Dermatitis, Atopic; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Emulsions; Finland; Humans; Prospective Studies; Severity of Illness Index; Skin; Time Factors; Treatment Outcome; Urocanic Acid | 2014 |
9 other study(ies) available for urocanic acid and Dermatitis, Atopic
| Article | Year |
|---|---|
Handheld confocal Raman spectroscopy (CRS) for objective assessment of skin barrier function and stratification of severity in atopic dermatitis (AD) patients.
Topics: Adult; Case-Control Studies; Ceramides; Dermatitis, Atopic; Epidermis; Feasibility Studies; Female; Healthy Volunteers; Humans; Hydrogen-Ion Concentration; Male; Point-of-Care Systems; Prospective Studies; ROC Curve; Severity of Illness Index; Spectrum Analysis, Raman; Support Vector Machine; Urocanic Acid; Water; Water Loss, Insensible | 2020 |
Filaggrin deficiency leads to impaired lipid profile and altered acidification pathways in a 3D skin construct.
Topics: Acids; Dermatitis, Atopic; Fatty Acids, Nonesterified; Filaggrin Proteins; Gene Knockdown Techniques; Group II Phospholipases A2; Humans; Hydrogen-Ion Concentration; Intermediate Filament Proteins; Lipid Metabolism; Permeability; Pyrrolidonecarboxylic Acid; Skin; Sodium-Hydrogen Exchangers; Urocanic Acid | 2014 |
South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin.
Topics: Adolescent; Adult; Carboxylic Acids; Child; Child, Preschool; Dermatitis, Atopic; DNA Mutational Analysis; Epidermis; Female; Filaggrin Proteins; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Infant; Intermediate Filament Proteins; Male; Mutation, Missense; Polymorphism, Genetic; Proteolysis; Pyrrolidinones; Risk; South Africa; Urocanic Acid; Young Adult | 2014 |
Urocanic Acid: An Endogenous Regulator of Langerhans Cells.
Topics: Adoptive Transfer; Animals; Dermatitis, Atopic; Disease Models, Animal; Disease Susceptibility; Histidine Ammonia-Lyase; Humans; Immune Tolerance; Langerhans Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Picryl Chloride; T-Lymphocytes, Regulatory; Ultraviolet Rays; Urocanic Acid | 2016 |
Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus.
Topics: Adhesins, Bacterial; Cell Growth Processes; Coagulase; Dermatitis, Atopic; Filaggrin Proteins; Humans; Hydrogen-Ion Concentration; Immune Evasion; Intermediate Filament Proteins; Mutation; Pyrrolidonecarboxylic Acid; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Urocanic Acid | 2010 |
Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity.
Topics: Child; Child, Preschool; Dermatitis, Atopic; Female; Filaggrin Proteins; Genetic Predisposition to Disease; Genotype; Humans; Intermediate Filament Proteins; Male; Mutation; Pyrrolidonecarboxylic Acid; Severity of Illness Index; Skin; Urocanic Acid | 2011 |
Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect.
Topics: Adult; Case-Control Studies; Child, Preschool; Dermatitis, Atopic; Female; Filaggrin Proteins; Gene Dosage; Genetic Predisposition to Disease; Genotype; Humans; Intermediate Filament Proteins; Ireland; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Skin; Urocanic Acid | 2012 |
Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations.
Topics: Adult; Child; Cohort Studies; Denmark; Dermatitis, Atopic; Dietary Supplements; Female; Filaggrin Proteins; Genetic Association Studies; Germany; Humans; Infant; Intermediate Filament Proteins; Male; Middle Aged; Mutation; Skin; Ultraviolet Rays; Urocanic Acid; Vitamin D | 2012 |
A non-invasive chamber sampling technique for HPLC analysis of human epidermal urocanic acid isomers.
Topics: Chromatography, High Pressure Liquid; Dermatitis, Atopic; Epidermis; Humans; Isomerism; Specimen Handling; Urocanic Acid | 1991 |